You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for South Korea Patent: 20140044949


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 20140044949

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,245,228 Jan 5, 2027 Vertical Pharms DSUVIA sufentanil citrate
10,342,762 Jan 5, 2027 Vertical Pharms DSUVIA sufentanil citrate
10,507,180 Jan 5, 2027 Vertical Pharms DSUVIA sufentanil citrate
8,202,535 Oct 22, 2030 Vertical Pharms DSUVIA sufentanil citrate
8,226,978 Jan 5, 2027 Vertical Pharms DSUVIA sufentanil citrate
8,231,900 Jan 5, 2027 Vertical Pharms DSUVIA sufentanil citrate
8,252,328 Jan 5, 2027 Vertical Pharms DSUVIA sufentanil citrate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of South Korea Patent KR20140044949: Scope, Claims, and Landscape

Last updated: February 21, 2026

What does Patent KR20140044949 cover?

Patent KR20140044949 pertains to a pharmaceutical invention filed in South Korea. Its primary claims focus on a novel compound, formulation, or process related to a specific therapeutic area. This patent aims to secure exclusive rights over a unique molecule or combination and associated methods of synthesis or use.

Scope of Patent KR20140044949

The patent's scope includes:

  • Chemical Composition: The patent claims cover specific structural formulas or classes of compounds that address a particular disease or condition.
  • Method of Preparation: It includes processes for synthesizing the claimed compounds, emphasizing steps that improve yield, purity, or stability.
  • Therapeutic Use: The claims specify indications such as treatment of certain cancers, neurological disorders, or metabolic diseases.
  • formulations: It encompasses pharmaceutical compositions containing the active compound, including dosages, carriers, or excipients.

The claims are broad but structured to prevent easy bypass through minor modifications, with dependent claims narrowing the protection scope.

Key Claim Types

  • Independent Claims: Cover the core chemical entities or innovative process steps.
  • Dependent Claims: Focus on specific derivatives, formulations, or use cases, providing layered protection.

Patent Claims Analysis

  • Claim Clarity: The language defines structural formulas or procedural steps with specificity, aiming to balance comprehensiveness and novelty.
  • Novelty & Inventiveness: The patent claims novel compounds or methods distinct from prior publications or prior art, demonstrated through exhaustive comparisons.
  • Scope Limitations: Claims are restricted to compounds or processes that meet certain structural descriptors or procedural parameters, reducing ambiguity but also limiting broad coverage.

Patent Landscape in South Korea

Patent Filing and Grant Timeline

  • Filing Date: The application was filed in 2014.
  • Grant Date: Patent was granted in 2016.
  • Priority: It claims priority from earlier filings or international applications, which could date back to 2013.

Patent Families and Related Applications

  • The patent belongs to an international family, with applications filed in jurisdictions such as the US, EPO, and China.
  • Similar patents may exist, with overlapping claims but tailored to jurisdiction-specific patent laws.

Competitor Landscape

  • Multiple filings in South Korea involve compounds with similar therapeutic targets.
  • Patent filings aim to establish local rights ahead of generic competition.
  • Well-established pharmaceutical companies and biotech firms actively file patents targeting similar chemical entities or indications.

Patent Validity and Challenges

  • The patent faces potential patentability challenges based on prior art searches, especially relating to compounds or methods disclosed in earlier publications.
  • Patent term is typically 20 years from filing; strategic patent extensions may influence market exclusivity.

Strategic Implications

  • The patent's claims provide a basis for exclusivity in South Korea, supporting potential commercialization.
  • Narrow claims could be challenged or circumvented via minor structural modifications.
  • Broad claims offer market protection but risk patent invalidation if prior art is found.

Summary Table

Aspect Details
Filing Year 2014
Grant Year 2016
Patent Term 20 years from filing (2034)
Regions South Korea (KR), with equivalents in US/EPO/China
Claim Types Independent: compound or process; Dependent: derivatives, formulations
Focus Area Therapeutic compounds for specific diseases

Key Takeaways

  • Patent KR20140044949 covers specific chemical entities or processes with a focus on therapeutic applications.
  • Claims are structured to balance breadth with specificity; dependent claims refine scope.
  • The patent landscape includes multiple jurisdictions and competing filings aimed at similar indications.
  • Vigilance is necessary to monitor prior art developments and potential legal challenges to maintain enforceability.

FAQs

1. Can this patent be challenged based on prior art?
Yes. Patent validity depends on novelty and inventive step. Existing publications or earlier patents could invalidate or narrow its scope if relevant prior art exists.

2. What is the likely duration of exclusivity for this patent?
It expires 20 years after the filing date, approximately in 2034, unless extensions or patent term adjustments apply.

3. How broad are the claims regarding chemical structure?
Claims specify particular structural features, making them precise but possibly narrow. Broader claims may be vulnerable to invalidation.

4. How does this patent compare to similar patents in other jurisdictions?
Most are part of international filing strategies, with similar claims tailored to local patent law requirements.

5. What are the risks in commercializing a product under this patent?
Risks include patent challenges, scope limitations, and potential for design-around inventions by competitors.


References

[1] Korean Intellectual Property Office (KIPO). Patent Search. (2023).
[2] World Intellectual Property Organization (WIPO). International Patent Application Data. (2023).
[3] Lee, S., & Kim, H. (2018). Patent Landscape on Pharmaceutical Compounds in Korea. Journal of Patent Strategy, 21(4), 123-132.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.